CLUSTER-HF: Lung Ultrasound Guided Therapy in Heart Failure

NACompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

April 10, 2018

Primary Completion Date

December 6, 2019

Study Completion Date

December 7, 2019

Conditions
Heart Failure
Interventions
COMBINATION_PRODUCT

LUS-guided therapy

Lung ultrasound guided therapy; if pulmonary congestion (more or equal than 3 B-lines), high dose (80-120mg PO/day furosemide) will be prescribed until next follow up re-assessment. If no congestion (less than 3 B-lines), low dose (0-40mg PO/day furosemide) will be prescribed until next follow up re-assessment

OTHER

Standard of Care

Standard of care will be provided.

Trial Locations (1)

14030

"Instituto Nacional de Cardiología Ignacio Chavez", Mexico City

All Listed Sponsors
lead

Instituto Nacional de Cardiologia Ignacio Chavez

OTHER

NCT03613779 - CLUSTER-HF: Lung Ultrasound Guided Therapy in Heart Failure | Biotech Hunter | Biotech Hunter